208 related articles for article (PubMed ID: 23134009)
1. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
2. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
3. Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
Ballanger F; Barbarot S; Le Gouill S; Gaillard F; Cassagnau E; Lodé L; Dréno B; Stalder JF
Acta Derm Venereol; 2009; 89(4):427-9. PubMed ID: 19688166
[No Abstract] [Full Text] [Related]
4. [Long-term survival after nasal NK/T cell lymphoma].
Rajnics P; Krenács L; Kenéz A; Járay Z; Bagdi E; Demeter J
Orv Hetil; 2008 Apr; 149(17):801-5. PubMed ID: 18426762
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
Oki Y; Younes A; Copeland A; Hagemeister F; Fayad LE; McLaughlin P; Shah J; Fowler N; Romaguera J; Kwak LW; Pro B
Br J Haematol; 2013 Jul; 162(1):138-41. PubMed ID: 23590726
[No Abstract] [Full Text] [Related]
6. [A case report of composite lymphoma].
Wu J; Wang ZC; Chen XD
Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
[No Abstract] [Full Text] [Related]
7. The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.
Ham JS; Kim SJ; Choi JY; Hyun SH; Choi SK; Kim HS; Lim SH; Lee JY; Jung SH; Ko YH; Kim WS
Blood Cancer J; 2016 Feb; 6(2):e395. PubMed ID: 26871713
[No Abstract] [Full Text] [Related]
8. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
[TBL] [Abstract][Full Text] [Related]
9. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
Chan KL; van der Weyden C; Khoo C; Lade S; Blombery P; Westerman D; Khot A; Melo B; Johnstone RW; Prince HM; Dickinson M
Leuk Lymphoma; 2017 Apr; 58(4):996-998. PubMed ID: 27558082
[No Abstract] [Full Text] [Related]
10. Improving therapy for patients with aggressive lymphoma.
Armitage JO
Transfus Apher Sci; 2011 Apr; 44(2):179-82. PubMed ID: 21345733
[TBL] [Abstract][Full Text] [Related]
11. Expression of constitutively activated NF-κB/mTORC pathway proteins and response to CHOP with bortezomib in a patient with angioimmunoblastic peripheral T-cell lymphoma.
Quesada AE; Rios A; Brown RE; Nguyen ND
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S87-9. PubMed ID: 25486962
[No Abstract] [Full Text] [Related]
12. Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?
Schleinitz N; Veit V; Coso D; Aurran T; Berbis P; Harle JR
Arch Dermatol; 2005 Mar; 141(3):395-6. PubMed ID: 15781686
[No Abstract] [Full Text] [Related]
13. Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
Jelinek T; Zuchnicka J
Blood; 2020 May; 135(20):1816. PubMed ID: 32407530
[No Abstract] [Full Text] [Related]
14. Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP.
Wilcox RA
Lancet Haematol; 2018 May; 5(5):e182-e183. PubMed ID: 29703333
[No Abstract] [Full Text] [Related]
15. [Initial treatment of diffuse large B-cell lymphoma].
Kinoshita T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():503-8. PubMed ID: 23134006
[No Abstract] [Full Text] [Related]
16. Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study.
Toya T; Nannya Y; Hangaishi A; Shiseki M; Shimoyama T; Sakamaki H; Motoji T; Usuki K; Nakamura F; Kurokawa M
Leuk Lymphoma; 2016; 57(4):961-4. PubMed ID: 26366623
[No Abstract] [Full Text] [Related]
17. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
Duan R; Zhang JZ
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
[No Abstract] [Full Text] [Related]
18. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
[No Abstract] [Full Text] [Related]
19. Therapies for peripheral T-cell lymphomas.
Savage KJ
Hematology Am Soc Hematol Educ Program; 2011; 2011():515-24. PubMed ID: 22160083
[TBL] [Abstract][Full Text] [Related]
20. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Ellin F; Landström J; Jerkeman M; Relander T
Blood; 2014 Sep; 124(10):1570-7. PubMed ID: 25006130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
